Osteoporosis and its complications are a major health concern in Saudi Arabia, and the prevalence of osteoporosis is on the rise. The aim of this study was to estimate the direct healthcare cost for patients with osteoporosis. A retrospective study was carried out among adult patients with osteoporosis in a teaching hospital in Saudi Arabia. A bottom-up approach was conducted to estimate the healthcare resources used and the total direct medical cost for the treatment of osteoporosis and related fractures. The study included 511 osteoporosis patients, 93% of whom were female. The average (SD) age was 68.5 years (10.2). The total mean direct medical costs for patients without fractures were USD 975.77 per person per year (PPPY), and for those with osteoporotic fractures, the total direct costs were USD 9716.26 PPPY, of which 56% of the costs were attributable to surgery procedures. Prior to fractures, the main cost components were medication, representing 61%, and physician visits, representing 18%. The findings of this study indicated the economic impact of osteoporosis and related fractures. With the aging population in Saudi Arabia, the burden of disease could increase significantly, which highlights the need for effective prevention strategies to minimize the economic burden of osteoporosis.

中文翻译：

---

沙特阿拉伯骨质疏松症的估计直接医疗成本：单中心回顾性成本分析

骨质疏松症及其并发症是沙特阿拉伯的一个主要健康问题，而且骨质疏松症的患病率正在上升。本研究的目的是估计骨质疏松症患者的直接医疗费用。在沙特阿拉伯的一家教学医院对成年骨质疏松症患者进行了一项回顾性研究。采用自下而上的方法来估算用于治疗骨质疏松症和相关骨折的医疗资源和总直接医疗费用。该研究包括 511 名骨质疏松症患者，其中 93% 是女性。平均 (SD) 年龄为 68.5 岁 (10.2)。无骨折患者的平均直接医疗总费用为每人每年 975.77 美元 (PPPY)，而对于骨质疏松性骨折患者，直接总费用为 9716.26 美元 PPPY，其中 56% 的费用可归因于手术程序。在骨折之前，主要的成本构成是药物（占 61%）和医生就诊（占 18%）。这项研究的结果表明骨质疏松症和相关骨折的经济影响。随着沙特阿拉伯人口老龄化，疾病负担可能显着增加，这凸显了制定有效预防策略以最大程度减少骨质疏松症的经济负担的必要性。